# Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer

> **NCT04669132** · PHASE2 · COMPLETED · sponsor: **Instituto Brasileiro de Controle do Cancer** · enrollment: 50 (actual)

## Conditions studied

- Nausea Post Chemotherapy

## Interventions

- **DRUG:** Olanzapine
- **DRUG:** Netupitant
- **DRUG:** Palonesetron

## Key facts

- **NCT ID:** NCT04669132
- **Lead sponsor:** Instituto Brasileiro de Controle do Cancer
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-17
- **Primary completion:** 2021-12-17
- **Final completion:** 2022-01-17
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04669132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04669132, "Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04669132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*